Corneal disease is the primary cause of visual loss in allergic eye disease. It occurs almost exclusively in vernal keratoconjunctivitis and atopic keratoconjunctivitis. It is characterized by ...

ICRS technology is a promising therapeutic option in corneal ectatic disease that avoids or postpones corneal graft. Crosslinking (CXL) provides a stiffer cornea. A significant change in ...

providing compelling evidence for the therapeutic potential of this pathway for a wide array of eye disorders. CEnC, corneal endothelial cells; PBS, phosphate-buffered saline.